Advertisement

Risk factors associated with hypoglycemic events after total pancreatectomy: A nationwide multicenter prospective study in Japan

      Abstract

      Background

      The number of total pancreatectomy cases have increased worldwide, expanding the need for new insulin products and high-titer pancrelipases. However, the current data that is focused on hypoglycemic events after a total pancreatectomy from large nationwide series are still lacking. This study is aimed to assess the risk factors associated with hypoglycemic events after a total pancreatectomy.

      Methods

      Data were prospectively collected from 216 consecutive patients who underwent total pancreatectomies between August 2015 and December 2017 from 68 Japanese centers. Of the 216 patients, 166 with a follow-up period of 1 year were analyzed. The risk factors for hypoglycemic events at 6 and 12 months (postoperative months 6 and 12) were investigated based on the results of a nationwide multicenter prospective study.

      Results

      Of the 166 patients, 57 (34%) and 70 (42%) experienced moderate or severe hypoglycemic events or hypoglycemia unawareness on a monthly basis at postoperative months 6 and 12, respectively. Multivariate analysis revealed that body weight loss after surgery ≥0.3 kg and total cholesterol level ≤136 mg/dL at postoperative month 6, and glycated hemoglobin level ≤8.9% and rapid-acting insulin use at postoperative month 12 were independent risk factors for hypoglycemic events after a total pancreatectomy. There were different independent risk factors depending on the postoperative period.

      Conclusion

      Patients with body weight loss after surgery, low total cholesterol level, strict glycemic control, and using rapid-acting insulin should be aware of the occurrence of hypoglycemic events after their total pancreatectomy. In order to prevent hypoglycemic events after a total pancreatectomy, we need to consider optimal nutritional and glycemic control according to the postoperative period.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Scavini M.
        • Dugnani E.
        • Pasquale V.
        • et al.
        Diabetes after pancreatic surgery: novel issues.
        Curr Diab Rep. 2015; 15: 16
        • Kiviluoto T.
        • Schroder T.
        • Karonen S.L.
        • Kuusi T.
        • Lempinen M.
        • Taskinen M.R.
        Glycemic control and serum lipoproteins after total pancreatectomy.
        Ann Clin Res. 1985; 17: 110-115
        • Dresler C.M.
        • Fortner J.G.
        • McDermott K.
        • Bajorunas D.R.
        Metabolic consequences of (regional) total pancreatectomy.
        Ann Surg. 1991; 214: 131-140
        • Duron F.
        • Duron J.J.
        Pancreatectomy and diabetes [article in French].
        Ann Chir. 1999; 53: 406-411
        • Sauvanet A.
        Functional results of pancreatic surgery [article in French].
        Rev Prat. 2002; 52: 1572-1575
        • Jethwa P.
        • Sodergren M.
        • Lala A.
        • et al.
        Diabetic control after total pancreatectomy.
        Dig Liver Dis. 2006; 38: 415-419
        • Datta J.
        • Lewis Jr., R.S.
        • Strasberg S.M.
        • et al.
        Quantifying the burden of complications following total pancreatectomy using the postoperative morbidity index: a multi-institutional perspective.
        J Gastrointest Surg. 2015; 19: 506-515
        • Roberts K.J.
        • Blanco G.
        • Webber J.
        • et al.
        How severe is diabetes after total pancreatectomy? A case-matched analysis.
        HPB (Oxford). 2014; 16: 814-821
        • Hartwig W.
        • Gluth A.
        • Hinz U.
        • et al.
        Total pancreatectomy for primary pancreatic neoplasms: renaissance of an unpopular operation.
        Ann Surg. 2015; 261: 537-546
        • Kakeji Y.
        • Takahashi A.
        • Udagawa H.
        • et al.
        Surgical outcomes in gastroenterological surgery in Japan: report of National Clinical database 2011-2016.
        Ann Gastroenterol Surg. 2018; 2: 37-54
        • Suto H.
        • Kamei K.
        • Kato H.
        • et al.
        Diabetic control and nutritional status up to 1 year after total pancreatectomy: a nationwide multicentre prospective study.
        Br J Surg. 2021; : 1-2
        • Kato H.
        • Kamei K.
        • Suto H.
        • et al.
        Incidence and risk factors of nonalcoholic fatty liver disease after total pancreatectomy: a first multicenter prospective study in Japan.
        J Hepatobilialy Pancreat Sci. 2022; 29: 428-438
      1. Frier B.M. Heller S. McCrimmon R. Hypoglycaemia in Clinical Diabetes. 3rd ed. Wiley-Blackwell, Chichester, UK2014
        • Pulvirenti A.
        • Pea A.
        • Rezaee N.
        • et al.
        Perioperative outcomes and long-term quality of life after total pancreatectomy.
        Br J Surg. 2019; 106: 1819-1828
        • Scholten L.
        • Latenstein A.E.J.
        • van Eijck C.
        • et al.
        Outcome and long-term quality of life after total pancreatectomy (PANORAMA): a nationwide cohort study.
        Surgery. 2019; 166: 1017-1026
        • Watanabe Y.
        • Ohtsuka T.
        • Matsunaga T.
        • et al.
        Long-term outcomes after total pancreatectomy: special reference to survivors' living conditions and quality of life.
        World J Surg. 2015; 39: 1231-1239
        • Epelboym I.
        • Winner M.
        • DiNorcia J.
        • et al.
        Quality of life in patients after total pancreatectomy is comparable with quality of life in patients who undergo a partial pancreatic resection.
        J Surg Res. 2014; 187: 189-196
        • Crippa S.
        • Tamburrino D.
        • Partelli S.
        • et al.
        Total pancreatectomy: indications, different timing, and perioperative and long-term outcomes.
        Surgery. 2011; 149: 79-86
        • Kiran R.P.
        • Turina M.
        • Hammel J.
        • Fazio V.
        The clinical significance of an elevated postoperative glucose value in nondiabetic patients after colorectal surgery: evidence for the need for tight glucose control?.
        Ann Surg. 2013; 258 (discussion 604–605): 599-604
        • Ambiru S.
        • Kato A.
        • Kimura F.
        • et al.
        Poor postoperative blood glucose control increases surgical site infections after surgery for hepato-biliary-pancreatic cancer: a prospective study in a high-volume institute in Japan.
        J Hosp Infect. 2008; 68: 230-233
        • Cheon Y.K.
        • Koo J.K.
        • Lee Y.S.
        • Lee T.Y.
        • Shim C.S.
        Elevated hemoglobin A1c levels are associated with worse survival in advanced pancreatic cancer patients with diabetes.
        Gut Liver. 2014; 8: 205-214
        • Fan K.Y.
        • Dholakia A.S.
        • Wild A.T.
        • et al.
        Baseline hemoglobin-A1c impacts clinical outcomes in patients with pancreatic cancer.
        J Natl Compr Canc Netw. 2014; 12: 50-57
        • Shi H.J.
        • Jin C.
        • Fu D.L.
        Impact of postoperative glycemic control and nutritional status on clinical outcomes after total pancreatectomy.
        World J Gastroenterol. 2017; 23: 265-274
        • Belyaev O.
        • Herzog T.
        • Chromik A.M.
        • Meurer K.
        • Uhl W.
        Early and late postoperative changes in the quality of life after pancreatic surgery.
        Langenbecks Arch Surg. 2013; 398: 547-555
        • Billings B.J.
        • Christein J.D.
        • Harmsen W.S.
        • et al.
        Quality-of-life after total pancreatectomy: is it really that bad on long-term follow-up?.
        J Gastrointest Surg. 2005; 9 (discussion 66–67): 1059-1066
        • Muller M.W.
        • Friess H.
        • Kleeff J.
        • et al.
        Is there still a role for total pancreatectomy?.
        Ann Surg. 2007; 246 (discussion 74–75): 966-974
        • Struyvenberg M.R.
        • Fong Z.V.
        • Martin C.R.
        • et al.
        Impact of treatments on diabetic control and gastrointestinal symptoms after total pancreatectomy.
        Pancreas. 2017; 46: 1188-1195
        • Karagianni P.
        • Sampanis C.
        • Katsoulis C.
        • et al.
        Continuous subcutaneous insulin infusion versus multiple daily injections.
        Hippokratia. 2009; 13: 93-96
        • Hanaire-Broutin H.
        • Melki V.
        • Bessieres-Lacombe S.
        • Tauber J.P.
        Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.
        Diabetes Care. 2000; 23: 1232-1235
        • DeVries J.H.
        • Snoek F.J.
        • Kostense P.J.
        • Masurel N.
        • Heine R.J.
        Dutch Insulin Pump Study G. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control.
        Diabetes Care. 2002; 25: 2074-2080
        • Tricco A.C.
        • Ashoor H.M.
        • Antony J.
        • et al.
        Comparative efficacy and safety of ultra-long-acting, long-acting, intermediate-acting, and biosimilar insulins for type 1 diabetes mellitus: a systematic review and network meta-analysis.
        J Gen Intern Med. 2021; 36: 2414-2426
        • Levin P.
        • Hoogwerf B.J.
        • Snell-Bergeon J.
        • Vigers T.
        • Pyle L.
        • Bromberger L.
        Ultra rapid-acting inhaled insulin improves glucose control in patients with type 2 diabetes mellitus.
        Endocr Pract. 2021; 27: 449-454
        • Geng Y.
        • Qi Q.
        • Sun M.
        • Chen H.
        • Wang P.
        • Chen Z.
        Prognostic nutritional index predicts survival and correlates with systemic inflammatory response in advanced pancreatic cancer. Eur.
        J Surg Oncol. 2015; 41: 1508-1514
        • Vashi P.
        • Popiel B.
        • Lammersfeld C.
        • Gupta D.
        Outcomes of systematic nutritional assessment and medical nutrition therapy in pancreatic cancer.
        Pancreas. 2015; 44: 750-755
        • Sutherland D.E.
        • Radosevich D.M.
        • Bellin M.D.
        • et al.
        Total pancreatectomy and islet autotransplantation for chronic pancreatitis.
        J Am Coll Surg. 2012; 214: 409-424
        • Chinnakotla S.
        • Beilman G.J.
        • Dunn T.B.
        • et al.
        Factors predicting outcomes after a total pancreatectomy and islet autotransplantation lessons learned from over 500 cases.
        Ann Surg. 2015; 262: 610-622
        • Young M.C.
        • Theis J.R.
        • Hodges J.S.
        • et al.
        Preoperative computerized tomography and magnetic resonance imaging of the pancreas predicts pancreatic mass and functional outcomes after total pancreatectomy and islet autotransplant.
        Pancreas. 2016; 45: 961-966
        • Quartuccio M.
        • Hall E.
        • Singh V.
        • et al.
        Glycemic predictors of insulin independence after total pancreatectomy with islet autotransplantation.
        J Clin Endocrinol Metab. 2017; 102: 801-809
        • Wilson G.C.
        • Sutton J.M.
        • Abbott D.E.
        • et al.
        Long-term outcomes after total pancreatectomy and islet cell autotransplantation: is it a durable operation?.
        Ann Surg. 2014; 260: 659-665
        • Ahmad S.A.
        • Lowy A.M.
        • Wray C.J.
        • et al.
        Factors associated with insulin and narcotic independence after islet autotransplantation in patients with severe chronic pancreatitis.
        J Am Coll Surg. 2005; 201: 680-687
        • Bramis K.
        • Gordon-Weeks A.N.
        • Friend P.J.
        • et al.
        Systematic review of total pancreatectomy and islet autotransplantation for chronic pancreatitis.
        Br J Surg. 2012; 99: 761-766
        • Tamborlane W.V.
        • Beck R.W.
        • Bode B.W.
        • et al.
        Continuous glucose monitoring and intensive treatment of type 1 diabetes.
        N Engl J Med. 2008; 359: 1464-1476
        • Julia F.
        • Roman H.
        Closed-loop control in insulin pumps for type-1 diabetes mellitus: safety and efficacy.
        Expert Rev Med Devices. 2020; 17: 707-720